Trial intelligence / Profile preview

Neural Mechanism of CAR Suppression on Cognition

NCT02799134Completed

Start
Nov 2015
Primary completion
Apr 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of dexamethasone (3 arms). Primary endpoint: Cortisol Awakening Response Level at 1 year. Started Nov 2015; status: completed.

02

Drugs

dexamethasone

Beyond the preview

Go deeper on NCT02799134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02799134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call